Evidence map›Paper›PMID 33786634›Full record

Observational studyOncology reports2021

Xinyu Liu, Hao Zhang, Pengcheng Zhou, Yaqun Yu, Haoye Zhang, Limin Chen, Jian Gong, Zhenguo Liu

Open access · hybridAbstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Oncology reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Xinyu LiuDepartment of Infectious Disease, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, P.R. China.
Hao ZhangDepartment of Nephrology, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, P.R. China.
Pengcheng ZhouDepartment of Infectious Disease, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, P.R. China.
Yaqun YuDepartment of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Guilin Medical College, Guilin, Guangxi 541002, P.R. China.
Haoye ZhangDepartment of Infectious Disease, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, P.R. China.
Limin ChenDepartment of Infectious Disease, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, P.R. China.
Jian GongDepartment of Infectious Disease, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, P.R. China.
Zhenguo LiuDepartment of Infectious Disease, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, P.R. China.
Central South University · CNThird Xiangya Hospital · CNAffiliated Hospital of Guilin Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is little information on the role of microRNA (miR)‑922 in the malignant behavior of liver cancer. The present study investigated the regulation of miR‑922 expression levels by cAMP response element binding protein 1 (

Indexed as

Gene Expression Regulation, NeoplasticAdultAgedAnimalsCell Line, TumorCyclic AMP Response Element-Binding ProteinFollow-Up StudiesHepatectomyHumansKaplan-Meier EstimateLiverLiver NeoplasmsMiceMicroRNAsMiddle AgedPromoter Regions, GeneticARID2 protein, humanCREB1 protein, humanCyclic AMP Response Element-Binding ProteinMicroRNAsMIRN922 microRNA, humanTranscription FactorsARID2CREB1liver cancermetastasismiRNAproliferation

Identifiers

PMID33786634
PMCPMC8020205
OpenAlexW3151227017

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.